Karin Wehlin

Directeur Général chez DIAGONAL BIO AB

Health Technology

Consumer Services

Technology Services

Profil

Karin Wehlin is the founder of EQL Pharma AB, founded in 2006.
Ms. Wehlin is currently Chief Executive Officer & Executive Director at Diagonal Bio AB since 2023.
Former jobs include Chief Executive Officer at LU Food Science AB, BoMill AB, and Respiratorius AB; Chairman at Duearity AB; and Chief Financial Officer at Nordic Drugs AB. Education includes an MBA from the University of Lund.

Postes actifs de Karin Wehlin

Sociétés	Poste	Début
DIAGONAL BIO AB	Directeur Général	23/11/2023

Tous les postes actifs de Karin Wehlin

Anciens postes connus de Karin Wehlin

Sociétés	Poste	Fin
Nordic Drugs AB	Directeur Financier/CFO	-
DUEARITY AB	Président	-
BOMILL AB	Directeur Général	-
LU Food Science AB	Directeur Général	-
RESPIRATORIUS AB	Directeur Général	-

Voir l'expérience en détail de Karin Wehlin

Formation de Karin Wehlin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Karin Wehlin

Sociétés liées

Entreprise privées	8
University of Lund University of Lund Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
EQL Pharma AB EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products	Health Technology
Respiratorius AB Respiratorius AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs to treat chronic obstructive pulmonary disease and asthma	Health Technology
Nordic Drugs AB
LU Food Science AB
BoMill AB BoMill AB Packaged SoftwareTechnology Services Develops and markets grain sorting technology	Technology Services
Duearity AB Duearity AB Medical SpecialtiesHealth Technology Develops hearing aids and related artificial intelligence based software	Health Technology
Diagonal Bio AB Diagonal Bio AB Medical SpecialtiesHealth Technology Develops pathogen diagnostic systems	Health Technology